Brain disease research has been revolutionized. The Simoa® digital immunoassay technology is highly sensitive when detecting CNS biomarkers in blood--up to 1000-times greater sensitivity than traditional analog ELISA technology--providing reliable quantification at ultra-low concentrations and unlocking new possibilities in neurology research and brain health management. Now, you can: • Measure CNS biomarkers across disease stages • Detect molecular changes earlier • Track biomarker dynamics in disease or recovery • Enhance sample stratification in research • Improveclinical trial enrollment and outcomes Learn more: https://lnkd.in/eq4Wc4tR #neurology #brainhealth #biomarkers
